Dendritic/tumor fusion cells as cancer vaccines
/in Dendritic Cells, International Publications /von 2012-06-01 / Semin. Oncol. 2012 Jun;39(3):287-95[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]
/in Acute Leukemia, Dendritic Cells, International Publications /von 2012-06-01 / Bull Cancer 2012 Jun;99(6):635-42Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.
/in Dendritic Cells, Hypernephroma, International Publications /von 2012-06-01 / J Clin Oncol 30, 2012 (suppl; abstr e15053)Cancer therapy and vaccination
/in Dendritic Cells, International Publications /von 2012-05-30 / J. Immunol. Methods 2012 Aug;382(1-2):1-23Cancer immunotherapy: a paradigm shift for prostate cancer treatment
/in Dendritic Cells, International Publications, Prostate Cancer /von 2012-05-29 / Nat Rev Urol 2012 May;9(7):376-85Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
/in International Publications, Newcastle Disease Virus /von 2012-05-29 / Appl. Biochem. Biotechnol. 2012 Aug;167(7):2005-22Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy
/in Dendritic Cells, Hyperthermia, International Publications, Ovarian Cancer /von 2012-05-05 / Case Rep Oncol 2012 May;5(2):212-5Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
/in Colorectal Cancer, Hyperthermia, International Publications /von 2012-05-01 / J. Cell. Biochem. 2012 May;113(5):1547-58Current status of immunological approaches for the treatment of prostate cancer
/in International Publications, Prostate Cancer /von 2012-05-01 / Curr Opin Urol 2012 May;22(3):197-202IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de